Patents by Inventor Isabelle Teulon

Isabelle Teulon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Production of antibody formats and immunological applications of said formats
    Patent number: 10385137
    Abstract: The invention concerns antibody formats comprising VH sequence of Camelidae, such as llamas; antibodies of various formats have anti-CEA or anti-CD16 VH sequences thereof; vectors expressing the antibody formats, and methods for producing the same.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: August 20, 2019
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Centre National de la Recherche Scientifique (CNRS), Universite d'Aix Marseille, Universite de Montpellier, Institut Regional du Cancer de Montpellier-Val D'Aurelle, Institut Paoli Calmettes
    Inventors: Daniel Baty, Ghislaine Behar, Martine Mansais, Andre Pelegrin, Jean-luc Teillaud, Isabelle Teulon
  • Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)
    Patent number: 9458239
    Abstract: The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
    Type: Grant
    Filed: September 5, 2012
    Date of Patent: October 4, 2016
    Assignee: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
    Inventors: Isabelle Teulon, André Pelegrin
  • PRODUCTION OF ANTIBODY FORMATS AND IMMUNOLOGICAL APPLICATIONS OF SAID FORMATS
    Publication number: 20160083476
    Abstract: The invention concerns antibody formats comprising VHsequence of Camelidae, such as llamas; antibodies of various formats have anti-CEA or anti-CD16 VH sequences thereof; vectors expressing the antibody formats, and methods for producing the same.
    Type: Application
    Filed: September 16, 2015
    Publication date: March 24, 2016
    Inventors: Daniel Baty, Ghislaine Behar, Martine Chartier, Andre Pelegrin, Jean-luc Teillaud, Isabelle Teulon
  • Production of antibody formats and immunological applications of said formats
    Patent number: 9169316
    Abstract: The invention concerns an in-vitro method for introducing a targeted genome modification into an oocyte or an egg and a method for performing a random insertion in the genome of a host cell.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: October 27, 2015
    Assignees: Centre National de la Recherche Scientifique-CNRS, INSERM (Institut National de la Sante et de la Recherche Medicale), Universite d'Aix Marseille, Universite de Montpellier, Institut Regional du Cancer de Montpellier-Val d'Aurelle, Institut Paoli Calmettes
    Inventors: Daniel Baty, Ghislaine Behar, Martine Chartier, André Pelegrin, Jean-luc Teillaud, Isabelle Teulon
  • MONOCLONAL ANTIBODIES AND FRAGMENT THEREOF DIRECTED AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II)
    Publication number: 20130164300
    Abstract: The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
    Type: Application
    Filed: September 5, 2012
    Publication date: June 27, 2013
    Inventors: Isabelle TEULON ET AL, André Pelegrin
  • Monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II)
    Patent number: 8278423
    Abstract: The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: October 2, 2012
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Isabelle Teulon, André Pelegrin
  • HUMAN ANTI-IDIOTYPIC ANTIBODY FRAGMENTS THAT MIMIC HER-2/NEU
    Publication number: 20110110929
    Abstract: This invention relates to human anti-idiotype antibody fragments, especially scFv, characterized by the ability to mimic Her-2/neu tumor associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients positive for Her-2/neu.
    Type: Application
    Filed: January 12, 2011
    Publication date: May 12, 2011
    Inventors: Philippe GAUTHIER, André Pelegrin, Mickaël Coelho, Isabelle Teulon
  • Human anti-idiotypic antibody fragments that mimic HER-2/neu
    Patent number: 7892542
    Abstract: This invention relates to human anti-idiotypic antibody fragments, especially scFv, characterized by the ability to mimic Her-2/neu tumor associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients positive for Her-2/neu.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: February 22, 2011
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Centre Regional de Lutte Contre le Cancer “Val d'Aurelle-Paul Lamarque”, Universite Montpellier I
    Inventors: Philippe Gauthier, André Pelegrin, Mickaël Coelho, Isabelle Teulon
  • MONOCLONAL ANTIBODIES AND FRAGMENT THEREOF DIRECTED AGAINST THE HUMAN ANTI-MULLERIAN HORMONE TYPE II RECEPTOR (AMHR-II)
    Publication number: 20100135996
    Abstract: The present invention relates to monoclonal antibodies and fragment thereof directed against the human Anti-Müllerian Hormone type II receptor (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian cancers.
    Type: Application
    Filed: October 31, 2007
    Publication date: June 3, 2010
    Inventors: Isabelle Teulon, André Pelegrin
  • Production of antibody formats and immunological applications of said formats
    Publication number: 20090202979
    Abstract: The invention concerns an in-vitro method for introducing a targeted genome modification into an oocyte or an egg and a method for performing a random insertion in the genome of a host cell.
    Type: Application
    Filed: June 13, 2007
    Publication date: August 13, 2009
    Applicants: Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Daniel Baty, Ghislaine Behar, Martine Chartier, Andre Pelegrin, Jean-Luc Teillaud, Isabelle Teulon
  • Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu
    Publication number: 20070298033
    Abstract: This invention relates to human anti-idiotypic antibody fragments, especially scFv, characterized by the ability to mimic Her-2/neu tumor associated antigen. These antibody fragments are promising candidates for active immunotherapy for cancer patients positive for Her-2/neu.
    Type: Application
    Filed: December 14, 2004
    Publication date: December 27, 2007
    Inventors: Philippe Gauthier, Andre Pelegrin, Mickael Coelho, Isabelle Teulon